Gilead Science (GILD) Followers | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Gilead Science (GILD) Followers

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
961	87	0	GILD

Emcee: SybilNicolas	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
436	Tom, I believe that the prophylactic benefit will be short term in institution	Doug Meetmer	-	9/30/1997
435	Tom: <Incidentally, I did not intend to imply anything about your investmen	scaram(o)uche	-	9/30/1997
434	10 to 14 days at the longest. I need the money to buy more SNUS and DEPO. I	Tom D	-	9/30/1997
433	Thanks for clearing up the natural reservoir/resistance issue for me. Incide	Tom D	-	9/30/1997
432	Tom, I agree with Miljenko's timetable. I also 100% agree with Rick's a	T. Mann	-	9/30/1997
431	Thanks for the information. I think you know more about this than I do. I don	Tom D	-	9/30/1997
430	Tom: Your points 2 and 3 are redundant. ;-) Regarding use as a prophylacti	scaram(o)uche	-	9/30/1997
429	Tom, Roche will be running the second smaller PIII in the spring of 1998, in th	T. Mann	-	9/30/1997
428	Did GILD get an exemption from the FDA requirement for two Phase III trials? T	Tom D	-	9/29/1997
427	<The problem with this concept of long-term prophylaxis with an antimicrobia	T. Mann	-	9/29/1997
426	Tom: Sorry if I offend you. It was not my attention. Only to point that anti-i	Miljenko Zuanic	-	9/29/1997
425	tdinovo and Doug: I don't see this drug being used much as prophylaxis. Do	Tom D	-	9/29/1997
424	Tom, to say that the use of ribavirin for influenza predicts the market size fo	T. Mann	-	9/29/1997
423	Miljenko, thanks for your thoughts. I'm not sure where you get the idea th	Tom D	-	9/29/1997
422	Tom: As an MD you should do much better. First educate your patients properly.	Miljenko Zuanic	-	9/29/1997
421	Tom, I've shorted some bios over the years with mixed results. A word of	tdinovo	-	9/29/1997
420	Doug, Could I impose on you for a little education? I am most intetested in	tdinovo	-	9/29/1997
419	Thanks for your comments. I have browsed through your postings in the past and	Tom D	-	9/29/1997
418	Doug I agree with you. . .except for the last part. Actually I think I have on	Tom D	-	9/29/1997
417	Tom: Sort of risky with PMPA out there? However, I don't disagree with yo	scaram(o)uche	-	9/29/1997
416	There are two issues. One is the value of the drug. The other is what will th	Doug Meetmer	-	9/29/1997
415	Thanks, Saadi. Been ass'd with the industry since its inception. Love bio	scaram(o)uche	-	9/29/1997
414	Thanks Rick..EOM? Iam also enjoying your posts on other biotech threads...you d	saadi taher	-	9/29/1997
413	I am also a practicing primary care MD and I just sold it short at 45. Most of	Tom D	-	9/29/1997
412	Cheers! <EOM>	scaram(o)uche	-	9/29/1997

Go to reply# or date (mm/dd/yy):